Accendra Health Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.6% | +2.3% | +1.8% | -4.2% | -8.4% | +4.3% | -14.5% | -2.8% | -39.3% | -1.5% | -12.8% | |
| – | -1.3% | +6.4% | +4.1% | -9.0% | -4.5% | +9.2% | +4.2% | -7.3% | -74.3% | +7.4% | -53.9% | |
| – | +12.9% | +0.8% | +5.0% | -82.3% | +8.6% | +20.4% | -35.6% | -14.2% | +758.8% | +19.5% | -97.7% | |
| – | +12.9% | +0.8% | +5.0% | -82.3% | +8.6% | +20.4% | -35.6% | -14.2% | +758.8% | +19.5% | -97.7% | |
| – | -12.4% | +12.0% | -0.8% | -0.4% | +4.3% | -15.9% | -66.2% | +3.2% | -52.7% | +8.1% | +15.8% | |
| – | +2.4% | +3.1% | +7.6% | +0.9% | -8.9% | +24.4% | -95.1% | -7.8% | +16.6% | -12.3% | +12.3% | |
| – | – | – | – | – | – | – | -58.0% | -0.2% | -3.6% | – | – | |
| – | +0.2% | -0.2% | 0.0% | +0.5% | -18.9% | +0.0% | -7.8% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -5.2% | -5.3% | -4.8% | -4.0% | -4.6% | -5.2% | -31.1% | -15.0% | -17.6% | -21.4% | -27.3% | |
| – | -1.6% | +3.5% | +3.0% | -5.3% | -2.8% | +4.8% | +3.5% | +0.7% | -34.8% | -1.1% | -7.7% | |
| – | +9.2% | +2.2% | +10.2% | -9.2% | -3.1% | +4.6% | +36.4% | -7.8% | -61.6% | +27.0% | -44.6% | |
| – | +148.8% | -25.4% | -0.8% | -77.8% | +5.7% | -1.7% | +755.1% | -34.4% | +4.7% | +98.2% | – | |
| – | -0.9% | +4.0% | +13.4% | -3.2% | -6.4% | +10.3% | -74.1% | -4.8% | +7.0% | +3.1% | -5.9% | |
| – | – | – | – | – | -2.3% | +5.1% | -15.7% | +15.1% | -1.9% | -15.4% | +12.9% | |
| – | +4.2% | -3.2% | -3.8% | +1.6% | -35.4% | +1.0% | -149.2% | – | – | – | – | |
| – | +5.1% | -5.9% | -9.2% | -4.1% | -98.0% | -83.1% | -85,578.9% | – | – | – | – | |
| – | +2.1% | -1.9% | +0.5% | +0.5% | +0.1% | +0.1% | -0.4% | +0.5% | -0.8% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.